Loading
New York neuro-oncologist who led INTELLANCE-1, the trial that tested the EGFR-directed antibody-drug conjugate depatuxizumab mafodotin in newly diagnosed glioblastoma and found it did not extend survival.
Andrew Lassman is chief of neuro-oncology at Columbia University Irving Medical Center. He was the lead investigator and first author of the 2023 Neuro-Oncology report of INTELLANCE-1, the phase 3 trial of depatuxizumab mafodotin added to radiotherapy and temozolomide in EGFR-amplified newly diagnosed glioblastoma, which showed no overall survival benefit despite earlier promise. He leads several cooperative-group glioma trials.
| Title | Journal | Year |
|---|---|---|
| Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions Europe PMC author record matched by affiliation (Herbert Irving Comprehensive Cancer Center, Columbia University); 999 citations on Europe PMC. | Neuro-Oncology | 2020 |
| Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline Europe PMC author record matched by affiliation (Herbert Irving Comprehensive Cancer Center, Columbia University); 691 citations on Europe PMC. | Journal of Clinical Oncology | 2022 |
| RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults Europe PMC author record matched by affiliation (Herbert Irving Comprehensive Cancer Center, Columbia University); 389 citations on Europe PMC. | Journal of Clinical Oncology | 2023 |
One of the most cited papers Europe PMC returns for Andrew B. Lassman at Herbert Irving Comprehensive Cancer Center, Columbia University, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Andrew B. Lassman at Herbert Irving Comprehensive Cancer Center, Columbia University, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Andrew B. Lassman at Herbert Irving Comprehensive Cancer Center, Columbia University, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
Shares Brain and spinal cord tumours (all types), Glioma & glioblastoma and the tags brain, trialist.
Shares Brain and spinal cord tumours (all types) and the tags brain, trialist.
Shares Brain and spinal cord tumours (all types) and the tags brain, trialist.
Shares Brain and spinal cord tumours (all types) and the tags brain, trialist.
Shares Glioma & glioblastoma and the tags brain, trialist.
Shares the tags brain, trialist.
Shares the tags brain, trialist.
Shares the tags brain, trialist.